A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response.

Saved in:
Bibliographic Details
Title: A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response.
Authors: Vestermark, L. W.1 lene.vestermark@ouh.regionsyddanmark.dk, Holtved, E.1, Dahlrot, R.1, Brimnes, M. K.2, Svane, I M.2,3, Bastholt, L.1
Source: Ecancermedicalscience. 2008, Vol. 2, p1-12. 12p. 2 Charts, 3 Graphs.
Database: Academic Search Ultimate
Description
ISSN:17546605
DOI:10.3332/ecancer.2008.91